Edward M. MD Kaye

Director

Edward M. MD Kaye (Director) filed 10 Form 4 reports in the trailing twelve months (0 purchases, 10 sales), most often in Cytokinetics, Incorporated (CYTK). The largest single filing was $1.9M of CYTK (28,064 sh × $66.72, as filed), executed Dec 1 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 10 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$5.8M

shares × price, as filed

Last traded

Aug 18

Filed Aug 18

Median ADV $25.8M across their filed names

Open performance→

Volume by month

Buys $0 Sells $8.1M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 10 filings

Sector per market data · by filing · past 12 months

Most traded names

CYTK

Cytokinetics, Incorporated CYTK · 0 buys · 7 sells 7 filings STOK

Stoke Therapeutics, Inc. STOK · 0 buys · 7 sells 7 filings

Recent filings

STOKSALE Stoke Therapeutics, Inc. View filing → $1.1M
42,461 sh × $25.09
Exec Oct 3 2025
Filed Oct 7 2025 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $369K
6,695 sh × $55.08
Exec Sep 30 2025
Filed Sep 30 2025 · 5:30 PM ET STOKSALE Stoke Therapeutics, Inc. View filing → $1.2M
60,856 sh across 2 lots
Exec Sep 2 2025
Filed Sep 3 2025 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $338K
6,756 sh × $50.00
Exec Sep 2 2025
Filed Sep 2 2025 · 5:30 PM ET STOKSALE Stoke Therapeutics, Inc. View filing → $221K
12,126 sh × $18.24
Exec Aug 18 2025
Filed Aug 20 2025 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $117K
3,636 sh × $32.10
Exec Jun 5 2025
Filed Jun 5 2025 · 5:30 PM ET